Diet and lifestyle factors associated with premenstrual symptoms in a racially diverse community sample: Study of Women's Health Across the Nation (SWAN)

Journal of Women's Health

Volumn 16, Issue 5, 2007, Pages 641-656

  Gold, Ellen B ^a,i   Bair, Yali ^b   Block, Gladys ^c   Greendale, Gail A ^d   Harlow, Siobán D ^e   Johnson, Susan ^f   Kravitz, Howard M ^g   Rasor, Marianne O'Neill ^a   Siddiqui, Amna ^a   Sternfeld, Barbara ^h   Utts, Jessica ⁱ   Zhang, Guili ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Planned Parenthood Affiliates of California   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF IOWA   (United States)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

^h DIVISION OF RESEARCH   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; FAT; PHYTOESTROGEN;

ADULT; ALCOHOL CONSUMPTION; ANXIETY; ARTICLE; BACKACHE; BLOATING; COMORBIDITY; DEMOGRAPHY; DEPRESSION; DIET; DISEASE ASSOCIATION; ETHNICITY; EXERCISE; FEMALE; FOOD INTAKE; HEADACHE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MASTALGIA; MOOD CHANGE; MUSCLE CRAMP; PASSIVE SMOKING; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; SMOKING; SOCIAL STATUS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN CONTINENTAL ANCESTRY GROUP; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOOD PREFERENCES; HISPANIC AMERICANS; HUMANS; LIFE STYLE; MULTIVARIATE ANALYSIS; PREMENSTRUAL SYNDROME; PREVALENCE; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; WOMEN'S HEALTH;

EID: 34447631496     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2006.0202     Document Type: Article

References (63)

1. Freeman EW, Halbreich U. Premenstrual syndromes. Psychopharmacol Bull 1998;34:291.
2. Halbreich U, Endicott J, Lesser J. The clinical diagnosis and classification of premenstrual changes. Can J Psychiatry 1985;30:489.
3. Barnhart KT, Freeman EW, Sondheimer SJ. A clinician's guide to the premenstrual syndrome. Med Clin North Am 1995;79:1457.
4. ACOG committee opinion. Premenstrual syndrome. Number 155, April 1995 (replaces No. 66, January 1989). Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1995;50:80.
5. Brown WJ, FM Doran. Women's health. Consumers views for planning local health promotion and health care priorities. Aust NZ J Public Health 1996;20:149.
6. Campbell EM, Peterkin D, O'Grady K, Sanson-Fisher R. Premenstrual symptoms in general practice patients. Prevalence and treatment. J Reprod Med 1997; 42:637.
7. Sternfeld B, Swindle R, Chawla A, et al. Severity of premenstrual symptoms in a health maintenance organization population. Obstet Gynecol 2002;99:1014.
8. Thys-Jacobs S. Micronutrients and the premenstrual syndrome: The case for calcium. J Am Coll Nutr 2000;19:220.
9. Logue CM, Moos RH. Perimenstrual symptoms: Prevalence and risk factors. Psychosom Med 1986;48: 388.
10. Steiner M. Premenstrual syndrome and premenstrual dysphoric disorder: Guidelines for management J Psychiatry Neurosci 2000;25:459.
11. Thys Jacobs S, Starkey P, Bernstein D, Tian J. Calcium carbonate and the premenstrual syndrome: Effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group. Am J Obstet Gynecol 1998;179:444.
12. Burton JL, Wells M. The effect of phytoestrogens on the female genital tract. J Clin Pathol 2002;55:401.
13. Kim DR, Gyulai L, Freeman EW, Morrison MF, Baldassano C, Dube B. Premenstrual dysphoric disorder and psychiatric comorbidity. Arch Women Ment Health 2004;7:37.
14. Yonkers KA. Anxiety symptoms and anxiety disorders: How are they related to premenstrual disorders? J Clin Psychiatry 1997;58(Suppl 3):62.
15. Yonkers KA. The association between premenstrual dysphoric disorder and other mood disorders. J Clin Psychiatry 1997;58(Suppl 15):19.
16. Morse CA, Dudley E, Guthrie J, Dennerstein L. Relationships between premenstrual complaints and perimenopausal experiences. J Psychosom Obstet Gynaecol 1998;19:182.
17. Stewart DE, Boydell KM. Psychologic distress during menopause: Associations across the reproductive life cycle. Int J Psychiatry Med 1993;23:157.
18. Gold EB, Colvin A, Avis N, et al. Longitudinal analysis of vasomotor symptoms and race/ethnicity across the menopausal transition: Study of Women's Health Across the Nation (SWAN). Am J Public Health 2006;96:1226.
19. Gold EB, Block G, Crawford S, et al. Lifestyle and demographic factors in relation to vasomotor symptoms, baseline results from the Study of Women's Health Across the Nation (SWAN). Am J Epidemiol 2004;159:1189.
20. Sowers MF, Crawford S, Morgenstein D, et al. Design and methods of SWAN: A multicenter, multiethnic community-based cohort study of women and the menopausal transition. In: Lobo R, Marcus R, Kelsey J, eds. Menopause: Biology and pathophysiology. San Diego: Academic Press, 2000:175.
21. Block G, Hartman AM, Dresser CM, et al. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986;124:453.
22. Subar AF, Thompson FE, Kipnis V, et al. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: The Eat-ing at America's Table Study. Am J Epidemiol 2001; 154:1089.
23. Block G, Thompson F, Hartman AM, et al. Comparison of two dietary questionnaires validated against multiple dietary records collected during a 1-year period. J Am Diet Assoc 1992;92:686.
24. Block G, Norris JC, Mandel RM, DiSogra C. Sources of energy and six nutrients in diets of low-income Hispanic-American women and children: Quantitative data from the HHANES survey, 1982-1984. J Am Dietet Assoc 1995;95:195.
25. Reinli K, Block G. Phytoestrogen content of foods - A compendium of literature values. Nutr Cancer 1996;26:123.
26. U.S. Department of Agriculture, Agricultural Research Service. USDA National Nutrient Database for Standard Reference, Release 19. Nutrient Data Laboratory Home Page, 2006. www.ars.usda.gov/ba/ bhnrc/ndl Accessed November 15, 2006.
27. Ferris BG. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 1978;118:1.
28. Coghlin J, Hammond SK, Gann PH. Development of epidemiologic tools for measuring environmental tobacco smoke exposure. Am J Epidemiol 1989;130:696.
29. Sternfeld B, Ainsworth BA, Quesenberry CP Jr. Physical activity patterns in a diverse population of women. Prev Med 1999;28:313.
30. Baecke JAH, Burema J, Fritjers JER. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36:936.
31. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med 1991;32:705.
32. Barsky AJ, Goodson JD, Lane RS, Cleary PD. The amplification of somatic symptoms. Psychosom Med 1988;50:510.
33. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement 1977;1:385.
34. Goodwin PJ, Miller A, Del Giudice ME, et al. Elevated high-density lipoprotein cholesterol and dietary fat intake in women with cyclic mastopathy. Am J Obstet Gynecol 1998;179:430.
35. Boyd NF, McGuire V, Shannon P, et al. Effect of a low-fat high-carbohydrate diet on symptoms of cyclical mastopathy. Lancet 1988;2:128.
36. Donahoo WT, Elvine JA, Melanson EL. Variability in energy expenditure and its components. Curr Opin Clin Nutr Metab Care 2004;7:599.
37. Webb P. 24-Hour energy expenditure and the menstrual cycle. Am J Clin Nutr 1986;44:614.
38. Meijer GAL, Westerterp KR, Saris WHM, Tenhoor F. Sleeping metabolic rate in relation to body composition and the menstrual cycle. Am J Clin Nutr 1992; 55:637.
39. Dalvit, SP. The effect of the menstrual cycle on patterns of food intake. Am J Clin Nutr 1981;34: 1811.
40. Dalvit-McPhillips SP. The effect of human menstrual cycle on nutrient intake. Physiol Behav 1983;31:209.
41. Caan B, Duncan D, Hiatt R, et al. Association between alcoholic and caffeinated beverages and premenstrual syndrome. J Reprod Med 1993;38:630.
42. Rossignol AM, Bonnlander H. Caffeine-containing beverages, total fluid consumption, and premenstrual syndrome. Am J Public Health 1990;80:1106.
43. Kurzer MS. Hormonal effects of soy isoflavones: Studies in premenopausal and postmenopausal women. J Nutr 2000;130:660S.
44. Murkies AL, Wilcox G, Davis SR. Clinical review 92: Phytoestrogens. J Clin Endocrinol Metab 1998;83:297.
45. Lewis SJ, Heaton KW, Oakey RE, McGrigle HH. Lower serum estrogen concentrations associated with faster intestinal transit. Br J Cancer 1997;76:395.
46. Bendich A. Micronutrients in women's health and immune function. Nutrition 2001;17:858.
47. Bertone-Johnson ER, Hankinson SE, Bendich A, et al. Calcium and vitamin D intake and risk of incident premenstrual syndrome. Arch Intern Med 2005;165: 1246.
48. Kritz-Silverstein D, Wingard DL, Garland FC. The association of behavior and lifestyle factors with menstrual symptoms. J Womens Health Gend Based Med 1999;8:1185.
49. Baron JA. Smoking and estrogen related disease. Am J Epidemiol 2001;153:865.
50. Cohen LS, Soares CN, Otto MW, et al. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles. J Affect Disord 2002;70:125.
51. Gannon L, Luchetta T, Pardie L, Rhodes K. Perimenstrual symptoms: Relationships with chronic stress and selected lifestyle variables. Behav Med 1989;15: 149.
52. Choi PY, Salmon P. Symptom changes across the menstrual cycle in competitive sportswomen, exercisers and sedentary women. Br J Clin Psychol 1995; 34:447.
53. Prior JC, Vigna Y, Sciarretta D, et al. Conditioning exercise decreases premenstrual symptoms: A prospective controlled six month trial. Fertil Steril 1987;47:402.
54. Ramcharan S, Love EJ, Fick GH, Goldfien A. The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: Attributable risk and risk factors. J Clin Epidemiol 1992;45:377.
55. Deuster PA, Adera T, South-Paul J. Biological, social, and behavioral factors associated with premenstrual syndrome. Arch Fam Med 1999;8:122.
56. Johnson SR, McChesney C, Bean JA. Epidemiology of premenstrual symptoms in a nonclinical sample. I. Prevalence, natural history and help-seeking behavior. J Reprod Med 1988;33:340.
57. Schwarz L, Kindermann W. Changes in beta-endorphin levels in response to aerobic and anaerobic exercise. Sports Med 1992;13:25.
58. Grady-Weliky TA. Clinical practice. Premenstrual dysphoric disorder. N Engl J Med 2003;348:433.
59. Richards M, Rubinow DR, Daly RC, Schmidt PJ. Premenstrual symptoms and perimenopausal depression. Am J Psychiatry 2006;163:133.
60. Takeda T, Tasaka K, Sakata M, Murata Y. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women. Arch Womens Ment Health 2006;9:209.
61. Singh BB, Berman BM, Simpson RL, Annechild A. Incidence of premenstrual syndrome and remedy usage: A national probability sample study. Altern Ther Health Med 1998;4:75.
62. Stevinson C, Ernst E. Complementary/alternative therapies for premenstrual syndrome: A systematic review of randomized controlled trials. Am J Obstet Gynecol 2001;185:227.
63. Fugh-Berman A, Kronenberg F. Complementary and alternative medicine (CAM) in reproductive-age women: A review of randomized controlled trials. Reprod Toxicol 2003;17:137.